Concepedia

J. Braunger

JB

Statistics

Publications

2

Citations

32

H-Index

2

Active since

2010

Affiliations

Boehringer Ingelheim (Austria)(Current)

J. Braunger is an author at Boehringer Ingelheim (Austria) specializing in oncology, metastasis, and signal transduction.

Publications per year

2010–2011

2

Publications

2

BI 5700, a Selective Chemical Inhibitor of I B Kinase 2, Specifically Suppresses Epithelial-Mesenchymal Transition and Metastasis in Mouse Models of Tumor Progression

Margit A. Huber, Helena J. Maier, Memetcan Alacakaptan et al. · Genes & Cancer · 2010 · 20 citations · Full text

Medicine, Oncology, Pharmacology +17

Abstract A249: BI 853520, a potent and highly selective inhibitor of protein tyrosine kinase 2 (focal adhesion kinase), shows efficacy in multiple xenograft models of human cancer.

Ulrich A. Hirt, J. Braunger, Michael Schleicher et al. · Molecular Cancer Therapeutics · 2011 · 12 citations

Life Sciences, Oncology, Pharmacology +17

1–2 of 2